Design and in vitro characterization of small unilamellar niosomes as ophthalmic carrier of dorzolamide hydrochloride

References

• Liu X, Rasmussen CA, Gabelt BT, et al. Gene therapy targeting glaucoma: where are we? Surv Ophthalmol 2009;54:472–486
   PubMedGoogle Scholar
• Pisella PJ, Pouliquen P, Baudouin C. Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. Br J Ophthalmol 2002;86:418–423
   PubMed Web of Science ®Google Scholar
• Baudouin C, Hamard P, Liang H, et al. Conjunctival epithelial cell expression of interleukins and inflammatory markers in glaucoma patients treated over the long term. Ophthalmol 2004;111:2186–2192
   PubMed Web of Science ®Google Scholar
• Bharath S, Hiremath SR. Ocular delivery systems of pefloxacin mesylate. Pharmazie 1999;54:55–58
   PubMedGoogle Scholar
• Atluri H, Anand BS, Patel J, Mitra AK. Mechanism of a model dipeptide transport across blood-ocular barriers following systemic administration. Exp Eye Res 2004;78:815–822
   PubMed Web of Science ®Google Scholar
• Abraham S, Furtado S, Bharath S, et al. Sustained ophthalmic delivery of ofloxacin from an ion-activated in situ gelling system. Pak J Pharm Sci 2009;22:175–179
   PubMed Web of Science ®Google Scholar
• Mysore N, Sood A, Venugopalan P, Vyas SP. Controlled ocular drug delivery and vesicular systems: an overview. Indian Drugs 1996;33:431–442
   Google Scholar
• Saettone MF, Perini G, Santucci E, Alhaique F. Non-ionic surfactant vesicles as ophthalmic carriers. STP Pharma Sci 1996;6:94–98
   Google Scholar
• Maren TH. Carbonic anhydrase: general perspective and advances in glaucoma research. Drug Dev Res 1987;10:255–276
   Web of Science ®Google Scholar
• Sugrue MF. The preclinical pharmacology of dorzolamide hydrochloride, a topical carbonic anhydrase inhibitor. J Ocul Pharmacol Ther 1996;12:363–376
   PubMed Web of Science ®Google Scholar
• Vyas SP, Mysore N, Jaitely V, Venkatesan N. Discoidal niosome based controlled ocular delivery of timolol maleate. Pharmazie 1998;53:466–469
   PubMed Web of Science ®Google Scholar
• Aggarwal D, Kaur IP. Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system. Int J Pharm 2005;290:155–159
   PubMed Web of Science ®Google Scholar
• Guinedi AS, Mortada ND, Mansour S, Hathout RM. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharm 2005;306:71–82
   PubMed Web of Science ®Google Scholar
• Paul S, Mondol R, Ranjit S, Maiti S. Antiglaucomatic niosomal system: recent trend in ocular drug delivery Research. Int J Pharm Pharmaceut Sci 2010;2:15–18
   Google Scholar
• Gevariya HB, Patel J. A review on recent trends in niosomal antiglaucoma drug delivery system. WJPR 2012;1:39–49
   Google Scholar
• Manconi M, Sinico C, Valenti D, et al. Niosomes as carriers for tretinoin. I. Preparation and properties. Int J Pharm 2002;234:237–248
   PubMed Web of Science ®Google Scholar
• Hao Y, Zhao F, Li N, et al. Studies on a high encapsulation of colchicine by a niosome system. Int J Pharm 2002;224:73–80
   Web of Science ®Google Scholar
• Srinivas S, Anand KY, Hemanth A, Anitha M. Preparation and evaluation of niosomes containing aceclofenac. Dig J Nanomater Bios 2010;5:249–254
   Web of Science ®Google Scholar
• Yoshioka T, Sternberg B, Florence AT. Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span-20, 40, 60 and 80) and sorbitan triester (Span 85). Int J Pharm 1994;105:1–6
   Web of Science ®Google Scholar
• Ruckmani K, Sankar V. Formulation and optimization of Zidovudine niosomes. AAPS Pharm Sci Tech 2010;11:1119–1127
   PubMed Web of Science ®Google Scholar
• Yoshioka T, Sternberg B, Moody M, Florence AT. Niosomes from Span surfactants: relations between structure and form. J Pharm Pharmcol Supp 1992;44:1044
   Google Scholar
• Ahmed SG, Nahed DM, Samar M, Rania MH. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharm 2005;306:71–82
   PubMedGoogle Scholar
• Abdelbary G, El-Gendy N. Niosome-encapsulated gentamicin for ophthalmic controlled delivery. AAPS Pharm Sci Tech 2008;9:740–747
   PubMed Web of Science ®Google Scholar
• Zimmer AK, Kreuter J. Microspheres and Nps used in ocular drug delivery systems. Adv Drug Deliv Rev 1995;16:61–73
   Web of Science ®Google Scholar
• Van Hal DA, Bouwstra JA, Rensen AV, et al. Preparation and characterization of non-ionic surfactant vesicles. J Colloid Interface Sci 1996;178:263–273
   Web of Science ®Google Scholar
• Carafa M, Santucci E, Alhaique F, et al. Preparation and properties of new unilamellar non-ionic/ionic surfactant vesicles. Int J Pharm 1998;160:51–59
   Web of Science ®Google Scholar
• Junyapraset VB, Teeranachaideekul V, Supapem T. Effect of charged and non-ionic membrane additives on physicochemical properties and stability of niosomes. AAPS Pharm Sci Tech 2008;9:851–859
   PubMed Web of Science ®Google Scholar
• Agarwal R, Katare OP, Vyas SP. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for anti-psoriatic drug dithranol. Int J Pharm 2001;228:43–52
   PubMed Web of Science ®Google Scholar
• Gianasi E, Cociancich F, Uchegbu IF, et al. Pharmaceutical and biological characterization of a doxorubicin polymer conjugate (PK1) entrapped in sorbitan monostearate Span 60 niosomes. Int J Pharm 1997;148:139–148
   Web of Science ®Google Scholar
• Jain S, Umamaheswari B, Bhadra D, Jain NK. Ethosomes: a novel carrier for enhanced transdermal delivery of an anti-HIV agent. Indian J Pharm Sci 2004;66:72–81
   Google Scholar
• Betageri GV, Parsons DL. Drug encapsulation and release from multilamellar and unilamellar liposomes. Int J Pharm 1992;81:235–241
   Web of Science ®Google Scholar
• Popli H, Nair MS. Niosomal delivery of tenoxicam. Indian J Pharm Sci 1996;58:163–166
   Google Scholar
• Namdeo A, Jain NK. Niosomal delivery of 5-flurouracil. J Microencapsul 1999;16:731–740
   PubMed Web of Science ®Google Scholar
• Omaima NE, Ahmed HH. Formulation and evaluation of acetazolamide liposomes as an ocular drug delivery system. Int J Pharm 1997;158:121–127
   Google Scholar
• Darwish IA. Preparation and characterization of niosomes formed from mixed non-ionic surfactants and cholesterol in span 60/tweens/cholesterol niosomes. Alex J Pharm Sci 1998;12:33–38
   Google Scholar
• Rogerson A, Cummings J, Florence AT. Adriamycin-loaded niosomes: drug entrapment, stability and release. J Microencapsul 1987;4:321–328
   PubMed Web of Science ®Google Scholar
• Devaraj GN, Parakh SR, Devraj R, et al. Release studies on niosomes containing fatty alcohols as bilayer stabilizers instead of cholesterol. J Colloid Interface Sci 2002;251:360–365
   PubMed Web of Science ®Google Scholar
• Baillie AJ, Florence AT, Hume LR, et al. The preparation and properties of niosomes-nonionic surfactant vesicles. J Pharm Pharmacol 1985;37:863–868
   PubMed Web of Science ®Google Scholar
• Parmar JJ, Singh DJ, Hegde DD, et al. Development and evaluation of inhalational liposomal system of budesonide for better management of asthma. Indian J Pharm Sci 2010;72:442–448
   PubMed Web of Science ®Google Scholar
• Heurtault B, Saulnier P, Pech B, et al. Physicochemical stability of colloidal lipid particles. Biomaterials 2003;24:4283–4300
   PubMed Web of Science ®Google Scholar
• Huang Y, Rao Y, Chen J, et al. Polysorbate cationic synthetic vesicle for gene delivery. J Biomed Mater Res 2011;96A:513–519
   Google Scholar